EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients

Kyohei Fujii iD, Masahiro Nakano iD, Shogo Kawakami, Yuichi Tanaka iD, Takuro Kainuma, Hideyasu Tsumura, Ken-Ichi Tabata, Takefumi Satoh, Masatsugu Iwamura, Hiromichi Ishiyama iD

Current Oncology · 2023

DOI: 10.3390/curroncol30050383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Kyohei Fujii und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Kitasato University Hospital, 1-15-1 Kitasato, Minamiku, Sagamiharashi 252-0329, Japan. Hauptthemen laut MEDLINE: Radiosurgery, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The indications for stereotactic body radiotherapy (SBRT) for prostate cancer have increased. However, the relationships between adverse events and risk factors remain unclear. This study aimed to clarify associations between adverse events and dose index for prostate SBRT. Participants comprised 145 patients irradiated with 32–36 Gy in 4 fractions. Radiotherapy-related risk factors such as dose-volume histogram parameters and patient-related risk factors such as T stage and Gleason score were evaluated in a competing risk analysis. Median follow-up duration was 42.9 months. A total of 9.7% had acute Grade ≥ 2 GU toxicities and 4.8% had acute Grade ≥ 2 GI toxicities. A total of 11.1% had late Grade ≥ 2 GU toxicities and 7.6% had late Grade ≥ 2 GI toxicities. Two (1.4%) patients suffered from late Grade 3 GU toxicities. Similarly, two (1.4%) patients suffered from late Grade 3 GI toxicities. Acute GU and GI events correlated with prostate volume and dose to the hottest 10 cc volume (D10cc)/volumes receiving a minimum of 30 Gy (V30 Gy) of rectum, respectively. Late GI toxicity, frequency, and rectal hemorrhage correlated with rectal D0.1 cc/D1 cc, maximum dose to the bladder, and rectal D0.1 cc, respectively. Toxicities after prostate SBRT using 32–36 Gy/4 fractions were acceptable. Our analysis showed that acute toxicities correlated with volume receiving a medium dose level, and late toxicities correlated with highest point dose of organs at risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryProstatic NeoplasmsMaleHumansProstatePelvisRectum

Stichwörter der Autor:innen

gastrointestinal toxicitygenitourinary toxicityprostate cancerstereotactic body radiotherapy

Autor:innen und Institutionen

  • Division of Radiation Oncology, Kitasato University Hospital, 1-15-1 Kitasato, Minamiku, Sagamiharashi 252-0329, Japan.
  • Department of Radiation Oncology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minamiku, Sagamiharashi 252-0329, Japan.
  • Graduate School of Medical Sciences, Kitasato University, 1-15-1 Kitasato, Minamiku, Sagamiharashi 252-0329, Japan.
  • Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minamiku, Sagamiharashi 252-0329, Japan.

ORCID-Profile: Kyohei Fujii, Masahiro Nakano, Yuichi Tanaka, Hiromichi Ishiyama

Zitieren

APA

Fujii, K., Nakano, M., Kawakami, S., Tanaka, Y., Kainuma, T., Tsumura, H., Tabata, K. I., Satoh, T., Iwamura, M., & Ishiyama, H. (2023). Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients. Current Oncology. https://doi.org/10.3390/curroncol30050383

Vancouver

Fujii K, Nakano M, Kawakami S, Tanaka Y, Kainuma T, Tsumura H, et al. Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients. Current Oncology. 2023. doi:10.3390/curroncol30050383

BibTeX
@article{Fujii2023,
  author = {Fujii, Kyohei and Nakano, Masahiro and Kawakami, Shogo and Tanaka, Yuichi and Kainuma, Takuro and Tsumura, Hideyasu and Tabata, Ken-Ichi and Satoh, Takefumi and Iwamura, Masatsugu and Ishiyama, Hiromichi},
  title = {Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30050383}
}
Kostenlos starten →